Population Representation: Everyone Must Play a Part
The responsibility of increasing diversity falls on every stakeholder in the clinical trial value chain.
The Impact of Trial Design on Interest by Race and Ethnicity
Survey examines trial enrollment motivation among diverse populations.
Tackling Trial Diversity Through Higher Innovation Standards
Advancing responsible AI innovation to help resolve patient disparities.
Strategies for Building Greater DE&I in Rare Disease Trials
Outlining new approaches and resources to help ignite progress in this area.
Rebooting the Statistic That 5% of Eligible Patients Participate in Clinical Trials
Self-determined eligibility and the influence of clinical care challenge this flawed figure.
eCOA Systems and the CE Mark: Navigating the Regulations
EU Medical Device Regulation must be followed carefully as it leaves room for interpretation.
Quality Tolerance Limits: A Review of Industry Trends
Industry sees high increase in the use of QTLs.
Diversity Plans, Sharing for Meaningful Change
Panel discussion at SCOPE highlights strategies to increase diversity in clinical trials.
Hints on Looming Changes to European Clinical Trial Rules
Reformed EMA looks to tackle challenges in drug development, pediatric medicines, and unmet medical need.
Is it Time to Adjust Our Approach to Learning?
Noise in modern day life may be interfering with our ability to learn.
Applied Clinical Trials March 2023 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials March 2023 issue in an interactive PDF format.
Maximizing Success in Rare Disease Studies
Sanjay Shukla, MD, MS, CEO of aTyr Pharma, discusses the company's clinical operations and ongoing Phase III study for pulmonary sarcoidosis.
Clinical Trial Diversity Continues to Face Challenges
With industry’s uneven track record in patient representation, sponsors now mandated to submit Diversity Action Plans (DAPs) to FDA for Phase III and pivotal studies.
A Singular Root Cause Undermines Clinical Trial Success: Leveraging Best Practice from 50 Years of Applied Research
Researchers face various challenges that cause their clinical trials to fail to meet enrollment timelines, among other issues.
